These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17524498)
1. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland. Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498 [TBL] [Abstract][Full Text] [Related]
2. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Torres B; Aguilar F; Franco E; Sánchez E; Sánchez-Román J; Jiménez Alonso J; Núñez-Roldán A; Martín J; González-Escribano MF Arthritis Rheum; 2004 Jul; 50(7):2211-5. PubMed ID: 15248219 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland. Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509 [TBL] [Abstract][Full Text] [Related]
4. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders. Suppiah V; Alloza I; Heggarty S; Goris A; Dubois B; Carton H; Vandenbroeck K J Neuroimmunol; 2005 Jul; 164(1-2):148-53. PubMed ID: 15904974 [TBL] [Abstract][Full Text] [Related]
5. The CTLA4+49A/G and CT60 polymorphisms and chronic inflammatory arthropathies in Northern Ireland. Suppiah V; O'Doherty C; Heggarty S; Patterson CC; Rooney M; Vandenbroeck K Exp Mol Pathol; 2006 Apr; 80(2):141-6. PubMed ID: 16248997 [TBL] [Abstract][Full Text] [Related]
6. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Yousefipour G; Erfani N; Momtahan M; Moghaddasi H; Ghaderi A Acta Neurol Scand; 2009 Dec; 120(6):424-9. PubMed ID: 19737153 [TBL] [Abstract][Full Text] [Related]
7. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients. Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605 [TBL] [Abstract][Full Text] [Related]
8. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis. Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880 [TBL] [Abstract][Full Text] [Related]
9. No evidence of a significant role for CTLA-4 in multiple sclerosis. Roxburgh RH; Sawcer S; Maranian M; Seaman S; Hensiek A; Yeo T; Deans J; Compston A J Neuroimmunol; 2006 Feb; 171(1-2):193-7. PubMed ID: 16325273 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Suppiah V; Goris A; Alloza I; Heggarty S; Dubois B; Carton H; Antigüedad A; Mendibe M; McDonnell G; Droogan A; Hawkins S; Graham C; Vandenbroeck K Int J Immunogenet; 2005 Dec; 32(6):383-8. PubMed ID: 16313303 [TBL] [Abstract][Full Text] [Related]
11. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y Autoimmunity; 2005 Mar; 38(2):151-3. PubMed ID: 16040335 [TBL] [Abstract][Full Text] [Related]
12. Haplotypes in the CTLA4 region are associated with coeliac disease in the Irish population. Brophy K; Ryan AW; Thornton JM; Abuzakouk M; Fitzgerald AP; McLoughlin RM; O'morain C; Kennedy NP; Stevens FM; Feighery C; Kelleher D; McManus R Genes Immun; 2006 Jan; 7(1):19-26. PubMed ID: 16237465 [TBL] [Abstract][Full Text] [Related]
13. Ctla4 and multiple sclerosis in the Italian population. Malferrari G; Stella A; Monferini E; Saltini G; Proverbio MC; Grimaldi LM; Rossi-Bernardi L; Biunno I Exp Mol Pathol; 2005 Feb; 78(1):55-7. PubMed ID: 15596061 [TBL] [Abstract][Full Text] [Related]
14. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Umemura T; Ota M; Hamano H; Katsuyama Y; Muraki T; Arakura N; Kawa S; Kiyosawa K Am J Gastroenterol; 2008 Mar; 103(3):588-94. PubMed ID: 18341485 [TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population. Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128 [TBL] [Abstract][Full Text] [Related]
16. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome. Gottenberg JE; Loiseau P; Azarian M; Chen C; Cagnard N; Hachulla E; Puechal X; Sibilia J; Charron D; Mariette X; Miceli-Richard C Arthritis Res Ther; 2007; 9(2):R24. PubMed ID: 17341301 [TBL] [Abstract][Full Text] [Related]
17. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism. Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis. Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646 [TBL] [Abstract][Full Text] [Related]
19. CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease. Park KS; Baek JA; Do JE; Bang D; Lee ES Tissue Antigens; 2009 Sep; 74(3):222-7. PubMed ID: 19563524 [TBL] [Abstract][Full Text] [Related]